Impact of human immunodeficiency virus type 1 subtypes on virologic response and emergence of drug resistance among children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 trial

Deenan Pillay, A. Sarah Walker, Diana M. Gibb, Anita De Rossi, Steve Kaye, Mounir Ait-Khaled, Maria Muñoz-Fernandez, Abdel Babiker, C. Boucher, C. Loveday, M. Muñoz Fernandez, C. Rouzioux, J. P. Aboulker, A. Compagnucci, J. Darbyshire, M. Debré, M. Gersten, C. Giaquinto, A. Jones, D. DunnL. Harper, D. Johnson, P. Kelleher, L. Mc Gee, A. Newberry, A. Poland, V. Eliette, S. Leonardo, Y. Saidi, S. Blanche, A. B. Bohlin, K. Butler, G. Castelli-Gattinara, P. Clayden, A. Faye, C. Griscelli, I. Grosch-Wörner, J. Levy, H. Lyall, M. Mellado Pena, D. Nadal, C. Peckham, J. T.Ramos Amador, L. Rosado, C. Rudin, H. Scherpbier, M. Sharland, P. A. Tovo, G. Tudor-Williams, C. Müller, Paediatric European Network for Treatment of AIDS (PENTA)

Research output: Contribution to journalArticleResearchpeer-review

84 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Impact of human immunodeficiency virus type 1 subtypes on virologic response and emergence of drug resistance among children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Neuroscience

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science